scholarly journals BIOCONTROL OF TEAK CANKER CAUSED BY Lasiodiplodia theobromae

2018 ◽  
Vol 42 (3) ◽  
Author(s):  
Rafaela Cristina Ferreira Borges ◽  
Eder Marques ◽  
Monica Alves Macedo ◽  
Irene Martins ◽  
José Getulio da Silva Filho ◽  
...  
Keyword(s):  
Pathogenic Fungus ◽  
In Vitro Assays ◽  
Timber Species ◽  
Bacillus Sp ◽  
Trichoderma Spp ◽  
Vitro Assay ◽  
Lasiodiplodia Theobromae ◽  
In Vivo Tests

ABSTRACT Teak is a forest species that has assumed great importance in Brazil, where it has found excellent conditions for development since its introduction into the country in the 1960s. However, phytosanitary problems are beginning to threaten the production of this timber species. An example is teak canker, caused by the fungus Lasiodiplodia theobromae (Lt), which has only recently been reported in Brazil, and for which, therefore, there are no recommended control methods. Thus, this study evaluated the control of this pathogen, investigating the potential of the biocontrol agents (BCAs) Trichoderma spp., Bacillus sp. and Enterobacter sp., initially through in vitro assays and, subsequently, with in vivo tests. According to the in vitro assay results, the Trichoderma isolates CEN162 and CEN1153 and the strain of Bacillus sp. (UnB1366) were the treatments that stood out, as they were able to completely inhibit mycelial growth of some isolates of Lt. When these isolates were tested in a preventive way, the control levels varied depending on the Lt isolate and the antagonist-clone interaction, where CEN162 (T. asperellum) and UnB166 (Bacillus sp.) showed 100% control. Thus, there is a positive correlation between the in vitro and in vivo tests, since the same BCAs stood out. Although good levels of control have been obtained with the BCAs used, it can be concluded that there is a variation in the antagonism to different Lt isolates or even in the antagonist-clone interaction, corroborating the information available in the scientific literature on this plant-pathogenic fungus.

scholarly journals Leucine-Rich Diet Modulates the Metabolomic and Proteomic Profile of Skeletal Muscle during Cancer Cachexia

Cancers ◽  
2020 ◽  
Vol 12 (7) ◽  
pp. 1880 ◽  
Author(s):  
Bread Cruz ◽  
André Oliveira ◽  
Lais Rosa Viana ◽  
Leisa Lopes-Aguiar ◽  
Rafael Canevarolo ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Cancer Cachexia ◽  
Energy Generation ◽  
In Vitro Assays ◽  
Proteomic Profile ◽  
Adult Rats ◽  
Vitro Assay ◽  
Tumour Bearing

Background: Cancer-cachexia induces a variety of metabolic disorders, including skeletal muscle imbalance. Alternative therapy, as nutritional supplementation with leucine, shows a modulatory effect over tumour damage in vivo and in vitro. Method: Adult rats distributed into Control (C), Walker tumour-bearing (W), control fed a leucine-rich diet (L), and tumour-bearing fed a leucine-rich diet (WL) groups had the gastrocnemius muscle metabolomic and proteomic assays performed in parallel to in vitro assays. Results: W group presented an affected muscle metabolomic and proteomic profile mainly related to energy generation and carbohydrates catabolic processes, but leucine-supplemented group (WL) recovered the energy production. In vitro assay showed that cell proliferation, mitochondria number and oxygen consumption were higher under leucine effect than the tumour influence. Muscle proteomics results showed that the main affected cell component was mitochondria, leading to an impacted energy generation, including impairment in proteins of the tricarboxylic cycle and carbohydrates catabolic processes, which were modulated and improved by leucine treatment. Conclusion: In summary, we showed a beneficial effect of leucine upon mitochondria, providing information about the muscle glycolytic pathways used by this amino acid, where it can be associated with the preservation of morphometric parameters and consequent protection against the effects of cachexia.

scholarly journals Preliminary Study and Improve the Production of Metabolites with Antifungal Activity by a Bacillus Sp Strain IBA 33

2009 ◽  
Vol 2 ◽  
pp. MBI.S995 ◽  
Author(s):  
María Antonieta Gordillo ◽  
Antonio Roberto Navarro ◽  
Lidia María Benitez ◽  
Marta Inés Torres De Plaza ◽  
Maria Cristina Maldonado
Keyword(s):  
Pathogenic Fungi ◽  
Geotrichum Candidum ◽  
Culture Conditions ◽  
Penicillium Expansum ◽  
In Vitro Assays ◽  
Bacillus Sp ◽  
In Vivo Assays ◽  
Metabolites Production

Bacillus sp strain IBA 33 metabolites, isolated from decaying lemon fruits, were evaluated for the control of pathogenic and non-pathogenic fungi ( Penicillium digitatum, Geotrichum candidum, Penicillium expansum, Aspergillus clavatus, Aspergillus flavus, Aspergillus niger, and Fusarium moniliforme). These metabolites were recovered from Landy medium (LM) without aminoacids. In order to optimize metabolites production the LM was modified by adding different concentrations and sources of amino acids and carbohydrates at different culture conditions. Bacillus sp strain IBA 33 metabolites efficacy to control fungi were evaluated with in vitro and in vivo assays. A. flavus growth inhibition was 52% with the metabolites of Bacillus sp strain IBA 33 recovered from LM (MBLM) in vitro assays. MBLM supplemented with 0.5% glutamic acid, inhibited the growth of P. digitatum, G. candidum, A. clavatus, A. niger and F. moniliforme by 65%, 88.44%, 84%, 34% and 92% respectively. The highest inhibition of P. expansum was 45% with MBLM supplemented with 0.5% aspartic acid. Similar results were obtained in vivo assays. These results showed that Bacillus sp strain IBA 33 metabolites specificity against fungi depended on the composition of the LM.

Assessment of Inhibition of Bovine Hepatic Cytochrome P450 by 43 Commercial Bovine Medicines Using a Combination of In Vitro Assays and Pharmacokinetic Data from the Literature

2020 ◽  
Vol 13 (2) ◽  
pp. 123-131
Author(s):  
Steven X. Hu ◽  
Chase A. Mazur ◽  
Kenneth L. Feenstra
Keyword(s):  
Liver Microsomes ◽  
In Vitro Assay ◽  
In Vitro Assays ◽  
Pharmacokinetic Studies ◽  
Pharmacokinetic Data ◽  
Vitro Assay ◽  
Administration Routes ◽  
Ic50 Values

Background: There has been a lack of information about the inhibition of bovine medicines on bovine hepatic CYP450 at their commercial doses and dosing routes. Objective: The aim of this work was to assess the inhibition of 43 bovine medicines on bovine hepatic CYP450 using a combination of in vitro assay and Cmax values from pharmacokinetic studies with their commercial doses and dosing routes in the literature. Methods: Those drugs were first evaluated through a single point inhibitory assay at 3 μM in bovine liver microsomes for six specific CYP450 metabolisms, phenacetin o-deethylation, coumarin 7- hydroxylation, tolbutamide 4-hydroxylation, bufuralol 1-hydroxylation, chlorzoxazone 6-hydroxylation and midazolam 1’-hydroxylation. When the inhibition was greater than 20% in the assay, IC50 values were then determined. The potential in vivo bovine hepatic CYP450 inhibition by those drugs was assessed using a combination of the IC50 values and in vivo Cmax values from pharmacokinetic studies at their commercial doses and administration routes in the literature. Results: Fifteen bovine medicines or metabolites showed in vitro inhibition on one or more bovine hepatic CYP450 metabolisms with different IC50 values. Desfuroylceftiour (active metabolite of ceftiofur), nitroxinil and flunixin have the potential to inhibit one of the bovine hepatic CYP450 isoforms in vivo at their commercial doses and administration routes. The rest of the bovine medicines had low risks of in vivo bovine hepatic CYP450 inhibition. Conclusion: This combination of in vitro assay and in vivo Cmax data provides a good approach to assess the inhibition of bovine medicines on bovine hepatic CYP450.

scholarly journals In Vitro Assays for Phototoxicity

1998 ◽  
Vol 17 (5) ◽  
pp. 567-570
Author(s):  
A. Kornhauser ◽  
R. R. Wei ◽  
W. G. Warner
Keyword(s):  
In Vitro Assay ◽  
In Vitro Assays ◽  
Vitro Assay ◽  
Cellular Targets ◽  
Photooxidative Damage ◽  
Us Government ◽  
Promising Area ◽  
Rna And Dna

This paper summarizes a few in vitro methods to assess photodamage in cells irradiated with UV of various wavelengths in the presence of a number of photo-sensitizers. A single in vitro assay for phototoxicity (photoirritation) is not likely to be predictive because of different mechanisms of phototoxicity and diverse cellular targets for injury. A number of methods have to be combined to provide a better prediction of these phenomena. Measurement of mechanistically relevant biomarkers also represents a promising area of in vitro testing for phototoxicity, and it is also briefly reviewed in this paper. Photodynamic sensitizers, representing a large class of phototoxic agents, can now be identified by sensitive measurement of photooxidative damage to cellular RNA and DNA. Currently, US government agencies have not identified a single in vitro assay for phototoxicity which would be acceptable for replacing an in vivo assay for regulatory purposes.

Biological Activity of Bacillus thuringiensis and Associated Toxins against the Asian Longhorned Beetle (Coleoptera: Cerambycidae)

2004 ◽  
Vol 39 (3) ◽  
pp. 318-324 ◽  
Author(s):  
Vincent D'Amico ◽  
John D. Podgwaite ◽  
Sara Duke
Keyword(s):  
Bacillus Thuringiensis ◽  
Brush Border Membrane ◽  
Membrane Vesicles ◽  
In Vitro Assays ◽  
Asian Longhorned Beetle ◽  
Negative Effects ◽  
In Vivo Tests ◽  
Longhorned Beetles

Bacillus thuringiensis Berliner var. tenebrionis and B. thuringiensis toxins were assayed against larval and adult Asian longhorned beetles, Anoplophora glabripennis (A. glabripennis). Preliminary in vitro assays showed some toxins to be active on whole midgut preparations in voltage clamp assays and in assays on brush border membrane vesicles formed from midgut epithelial cells. For in vivo tests, a commercially-available product (Novodor®) was incorporated into artificial diet, upon which larvae were allowed to feed ad lib. In other tests, droplets of solubilized B. thuringiensis toxins were fed to larval and adult beetles using a micropipette. None of the in vivo assays showed significant negative effects on either larvae or adults. We believe that some aspect of A. glabripennis midgut chemistry may be incompatible with toxin activation or mode of action.

Inhibition of nitric oxide synthesis improves detoxication in inflammatory liver dysfunction in vivo

1997 ◽  
Vol 273 (2) ◽  
pp. G530-G536 ◽  
Author(s):  
A. Veihelmann ◽  
T. Brill ◽  
M. Blobner ◽  
I. Scheller ◽  
B. Mayer ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
In Vitro Assays ◽  
Serum Concentrations ◽  
Aminopyrine Breath Test ◽  
Vitro Assay ◽  
Synthase Inhibitor ◽  
Cytochrome P 450 ◽  
Stimulation Of

Inflammatory stimulation of the liver induces nitric oxide (NO) biosynthesis and suppression of detoxication. In this study the effect of NO biosynthesis on cytochrome P-450 (CYP) enzyme activity was investigated by comparing in vivo and in vitro assays. To establish liver inflammation, CD rats were injected with Corynebacterium parvum (C. parvum) suspension. After 5 days NO biosynthesis was highly induced as indicated by increased NO2- plus NO3- serum concentrations. At the same time the aminopyrine breath test (ABT), measuring CYP activity in vivo, was reduced to 42% and the in vitro assay of aminopyrine turnover was suppressed to 12% of NaCl- injected controls. When C. parvum-injected animals were treated with the NO synthase inhibitor NG-monomethyl-L-arginine (L-NMMA), CYP activities significantly improved with an ABT of 76% and an in vitro aminopyrine turnover of 47% of controls. Neither C. parvum injections nor L-NMMA treatment resulted in a significant change of CYP protein concentrations. These data indicate that suppression of xenobiotic metabolism can be attenuated by inhibition of NO biosynthesis during an ongoing process of inflammation.

scholarly journals 1341. Development of a Series of High-Throughput Screens to Identify Leads for Nontuberculous Mycobacteria Drug Design

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S485-S485
Author(s):  
Sarah McGuffin ◽  
Steven Mullen ◽  
Julie Early ◽  
Tanya Parish
Keyword(s):  
Drug Discovery ◽  
Drug Development ◽  
High Throughput ◽  
Nontuberculous Mycobacteria ◽  
Human Infection ◽  
Attrition Rate ◽  
In Vitro Assays ◽  
Vitro Assay

Abstract Background Nontuberculous mycobacteria (NTM), particularly Mycobacterium avium complex and Mycobacterium abscessus complex, cause significant morbidity and mortality in patients with impaired host immunity or pre-existing structural lung conditions. NTM infections are increasing at an alarming rate worldwide and there is a dearth of progress in regard to the development of efficacious and tolerable drugs to treat such infections. Traditional drug discovery screens do not account for the diverse physiological conditions, microenvironments, and compartments that the bacilli encounter during human infection. In order to help populate the NTM drug pipeline, and explore the disconnect between in vitro activity, in vivo activity, and clinical outcomes, we are developing a high throughput in vitro assay platform that will more closely model the unique infection-relevant conditions encountered by NTM. Methods We are developing and validating a suite of in vitro assays that screen compounds for activity against extracellular planktonic bacteria, extracellular bacteria within biofilms, intracellular bacteria, and nutrient-starved non-replicating bacteria. Results We are using both the smooth and rough morphotypes of M. abscessus and M. avium. We have validated high throughput assays to pharmaceutical standards for replicating and non-replicating M. abscessus. We have also tested a panel of 18 known anti-mycobacterial compounds. Assay development is currently underway to test compounds for activity against NTM in biofilm and inside macrophages as well. Conclusion To enhance hit identification for scaffolds to use as starting points for NTM drug development, focused libraries of compounds that have undergone significant preclinical profiling and/or compounds with known activity against M. tuberculosis (TB) will be screened. Such a “piggyback” approach usurps advances made in TB drug development and leverages them for NTM drug discovery. This will help expedite novel drug development, reduce attrition rate, and offer a shorter route to clinical use as it exploits the prior investment in medicinal chemistry, pharmacology, and toxicology. Disclosures All authors: No reported disclosures.

scholarly journals USO DA MICROBIOLIZAÇÃO CONTRA Lasiodiplodia theobromae EM SEMENTES DE PINUS SPP.

FLORESTA ◽  
2017 ◽  
Vol 47 (1) ◽  
pp. 121
Author(s):  
Caciara Gonzatto Maciel ◽  
Marlove Fátima Brião Muniz ◽  
Jéssica Mengue Rolim ◽  
Rosa Maria Dalla Nora Michelon ◽  
Tales Poletto ◽  
...  
Keyword(s):  
Pinus Taeda ◽  
Pinus Elliottii ◽  
Bacillus Sp ◽  
Lasiodiplodia Theobromae ◽  
Pinus Spp

O uso de agentes biocontroladores no controle de doenças em plantas é uma alterativa aos produtos químicos que vem conquistando seu espaço, isso, devido a nossa condição atual de proteção e manutenção do meio ambiente. Muitos organismos antagonistas apresentam potencial tanto para o controle de fitopatógenos, quanto para promoção do desenvolvimento de plântulas. O presente estudo objetivou avaliar a ação antagonista de seis produtos biológicos (Trichodermil®, Trichodel®, Quality®, Rizos®, Rizolyptus® e Nutrisolo®) e uma cepa bacteriana (Bacillus sp.-UFSM) no controle in vitro e in vivo de Lasiodiplodia theobromae patogênico a Pinus sp.. Os testes in vitro foram realizados através da inibição do crescimento micelial (confronto pareado de culturas), após incubação por sete dias a 25 ± 2 ºC e fotoperíodo de 12 horas. Para os testes in vivo (desenvolvidos em condições de casa de vegetação), as sementes inicialmente foram inoculadas com o patógeno e, na sequência, microbiolizadas com os agentes antagônicos, para posterior semeadura. A inoculação foi realizada através do método de contato em meio BDA por 48 horas. Todos os produtos testados apresentaram resultados positivos nos testes in vitro, destacando-se em relação a testemunha. Nutrisolo®, Trichodel® e Bacillus sp.-UFSM apresentaram valores superiores a testemunha para diâmetro de colo em plântulas de P. elliottii. Enquanto para P. taeda, Bacillus sp.-UFSM, Quality®, Trichodel® e Trichodermil® alcançaram os maiores valores para essa variável. De maneira geral os agentes antagônicos atuaram promovendo as variáveis de qualidade final de mudas de Pinus taeda e Pinus elliottii.

scholarly journals Evaluation of Antagonism Activity and Control of Vibrio alginolyticus in Artemia Culture Using Mixed Probiotic

2021 ◽  
Vol 44 (1) ◽  
Author(s):  
Mei Yun Beryl Chean ◽  
Puvaneswari Puvanasundram ◽  
Jasmin Yaminudin ◽  
Murni Karim
Keyword(s):  
Vibrio Alginolyticus ◽  
In Vitro Assays ◽  
High Concentration ◽  
Immersion Method ◽  
Vitro Assay ◽  
Single Strain ◽  
Artemia Nauplii ◽  
And Control

Supplementation with mixed probiotic in aquaculture has been proven to benefit the hosts as disease resistance tool. In this study, a mixed probiotic which consisted of three isolated strains (Lysinibacillus fusiformis strain SPS11, A2, and Bacillus megaterium strain I24) was formulated for the in vitro assays against Vibrio alginolyticus and in vivo preliminary study towards Artemia nauplii. These strains showed antagonism activities against V. alginolyticus in in vitro assay. An increase in biofilm formation of this mixed probiotic was observed which indicated that the strains could work synergistically with each other to confer benefits to the hosts. Enrichment of Artemia nauplii with the formulated mixed probiotic was done to investigate its role in enhancing resistance against the V. alginolyticus. Artemia nauplii were cultured in two different concentrations of mixed probiotic (106 and 108 CFU mL-1) and challenged via immersion method. The mixed probiotic at both concentrations resulted in significantly higher survival of Artemia compared to the challenged group with no probiont added (106 CFU mL-1, 65.00 ± 0.00 % and 108 CFU mL-1, 77.50 ± 3.53 %). Significant reduction of Vibrio loads was observed in Artemia and its culture water supplemented with mixed probiotic at 108 CFU mL-1 whereas there was no reduction of Vibrio at 106 CFU mL-1. This study suggests that the usage of formulated mixed probiotic at high concentration (108 CFU mL-1) as opposed to single-strain probiotic can confer protection against V. alginolyticus infection towards Artemia.

scholarly journals Corrositex®, BCOP and HET-CAM as alternative methods to animal experimentation

2009 ◽  
Vol 45 (4) ◽  
pp. 759-766 ◽  
Author(s):  
Edith Cristina Laignier Cazedey ◽  
Flávia Chiva Carvalho ◽  
Flávia Angélica Másquio Fiorentino ◽  
Maria Palmira Daflon Gremião ◽  
Hérida Regina Nunes Salgado
Keyword(s):  
Chemical Properties ◽  
Alternative Methods ◽  
In Vivo Studies ◽  
In Vitro Assays ◽  
Promising Alternative ◽  
Animal Protection ◽  
In Vivo Tests ◽  
Pain And Suffering

Tests in animals are used as models in toxicological and investigative studies. However, such tests have been considered inhumane because they can cause pain and suffering to experimental animals, while these methods can often be subjective. Protests calling for animal protection have questioned the effectiveness of in vivo tests and suggest the introduction of alternative, in vitro methods. International organizations, such as the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), the National Institute of Health (NIH), the Organization for Economic Co-operation and Development (OECD), that regulate and develop new alternative animal models, have indicated the running of preliminary assays and execution of sequential tests, which consider physical-chemical properties and data of in vitro assays, before performing in vivo studies. Towards this background, the objective of the present article was to select promising alternative methods such as Corrositex®, BCOP and HET-CAM, intended to refine or replace the use of animals and reduce their suffering.

Sign in / Sign up

Export Citation Format

Share Document